The consistency with which VDR is upregulated in response to inhibition of miR-10b regardless of species, cancer type, or method and its status as a predicted target of miR-10b makes the gene particularly interesting for future studies in miR-10b-based therapies. The gene discussed is VDR; the disease is cancer.